国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年 第62号)

2020-10-02 CDE CDE

国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年 第62号)

国家药监局关于发布球囊扩张导管等6项指导原则的通告(2020年 第62号)

为加强医疗器械产品注册工作的监督和指导,进一步提高注册审查质量,国家药品监督管理局组织制定了《球囊扩张导管注册技术审查指导原则》《输注产品针刺伤防护装置要求与评价技术审查指导原则》《生物型股骨柄柄部疲劳性能评价指导原则》《同种异体植入性医疗器械病毒灭活工艺验证指导原则(2020年修订版)》《3D打印患者匹配下颌骨假体注册审查指导原则》《个性化匹配骨植入物及工具医工交互质控审查指导原则》,现予发布。
  特此通告。

附件:1.球囊扩张导管注册技术审查指导原则

     2.输注产品针刺伤防护装置要求与评价技术审查指导原则

     3.生物型股骨柄柄部疲劳性能评价指导原则

     4.同种异体植入性医疗器械病毒灭活工艺验证指导原则(2020年修订版)

     5.3D打印患者匹配下颌骨假体注册审查指导原则

     6.个性化匹配骨植入物及工具医工交互质控审查指导原则

 

国家药监局
2020年9月17日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2021-05-08 lsj637
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-04 xuyu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-04 花花1366
  6. [GetPortalCommentsPageByObjectIdResponse(id=1688442, encodeId=26ba168844282, content=<a href='/topic/show?id=360f686434a' target=_blank style='color:#2F92EE;'>#球囊扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68643, encryptionId=360f686434a, topicName=球囊扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=401d28589001, createdName=1249898am24暂无昵称, createdTime=Thu Apr 01 02:37:33 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752738, encodeId=5b6a1e527385a, content=<a href='/topic/show?id=13016864602' target=_blank style='color:#2F92EE;'>#球囊扩张导管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68646, encryptionId=13016864602, topicName=球囊扩张导管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d62936562906, createdName=jwf_2013, createdTime=Thu Apr 29 22:37:33 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684848, encodeId=557e168484890, content=<a href='/topic/show?id=794754e74f4' target=_blank style='color:#2F92EE;'>#扩张#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54774, encryptionId=794754e74f4, topicName=扩张)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=699d28086811, createdName=lsj637, createdTime=Sat May 08 17:37:33 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301720, encodeId=bcac1301e20ee, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384424, encodeId=3668138442405, content=<a href='/topic/show?id=2e956863556' target=_blank style='color:#2F92EE;'>#球囊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68635, encryptionId=2e956863556, topicName=球囊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429260, encodeId=e50c1429260dd, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sun Oct 04 06:37:33 CST 2020, time=2020-10-04, status=1, ipAttribution=)]

相关资讯

强生召回部分问题球囊扩张导管

美国 FDA网站上将“Dura Star” 和 “Fire Star”球囊导管召回事件定为最严重的“一级召回”。   中国网7月13日讯(记者 刘永晓 马艺文)7月12日,跨国制药企业强生公司再次出现召回事件:由于可能会出现“缓慢收缩”或“无法收缩”的问题,强生宣布召回Cordis公司生产的球囊扩张导管(商品Fire Star),涉及产品批号为15437344。   从国家药监局官方微博“中国